Abstract
Since anthracyclines were introduced in the treatment of non-Hodgkin's lymphoma in the late 1960s, they have been acknowledged as a cornerstone in the management of the disease and, in particular, of aggressive lymphomas. The high efficacy of anthracycline-containing regimens must, however, be balanced against the drug-related toxicity, which mainly affects the cardiovascular system and represents a major concern for clinicians, especially in the treatment of elderly patients. Patients' outcomes could be further improved, particularly for those at high risk of cardiotoxicity, by substituting liposomal doxorubicin for conventional doxorubicin. This approach has already been tested and shown to be effective in several cancers, especially in different subsets of patients with diffuse large B-cell lymphoma. The use of liposomal doxorubicin in combination regimens for other conditions, such as follicular lymphoma and splenic marginal zone lymphoma, is also under investigation, and early results are promising.
References
Jun 1, 1989·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·M FedericoR L Magin
Apr 8, 1993·The New England Journal of Medicine·R I FisherT P Miller
Aug 1, 1996·Leukemia & Lymphoma·M BertiniL Resegotti
Nov 15, 2001·Clinical Lymphoma·M BertiniR Calvi
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Feb 4, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S LimatJ Y Cahn
Oct 18, 2003·Journal of Cancer Research and Clinical Oncology·S M Swain, P Vici
Jan 24, 2004·Leukemia & Lymphoma·Luigi RigacciUNKNOWN Intergruppo Italiano Linfomi
Mar 16, 2004·Blood·Michael PfreundschuhUNKNOWN German High-Grade Non-Hodgkin's Lymphoma Study Group
Jul 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexandra M LevineLauri Welles
Feb 19, 2005·Seminars in Oncology·Theresa M Allen, Francis J Martin
Feb 19, 2005·Seminars in Oncology·Michael S EwerAlberto A Gabizon
May 4, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P FeugierB Coiffier
Aug 2, 2006·Clinical Lymphoma & Myeloma·Anil TulpuleAlexandra M Levine
Oct 31, 2006·Leukemia & Lymphoma·F ZajaR Fanin
Feb 28, 2007·Leukemia & Lymphoma·F MerliE Gallo
May 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catherine Thieblemont, Bertrand Coiffier
Jul 27, 2007·Hematological Oncology·Luigi RigacciAlberto Bosi
Jul 27, 2007·Hematological Oncology·Stefano LuminariMassimo Federico
Jan 30, 2008·The Lancet Oncology·Michael PfreundschuhUNKNOWN German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
Apr 22, 2008·The Cochrane Database of Systematic Reviews·E C van DalenL C M Kremer
Dec 17, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S LuminariM Federico
Jun 16, 2010·Blood·Bertrand CoiffierHervé Tilly
Citations
Mar 10, 2017·The Oncologist·Jacopo OlivieriGuido Gini
Apr 12, 2019·Current Opinion in Cardiology·Brian W Hardaway
Oct 25, 2013·Clinical Nuclear Medicine·Lorenzo MannelliHubert Vesselle
Mar 23, 2021·Therapeutic Advances in Hematology·Katrin Schmittlutz, Reinhard Marks